You are here

  • Home
  • Archive
  • Volume 23, Issue 3
  • Weekly Topotecan for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Tolerability and Efficacy Study—The Israeli Experience

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Weekly Topotecan for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Tolerability and Efficacy Study—The Israeli Experience

 

Online download statistics by month:

Online download statistics by month: March 2019 to March 2023

AbstractFullPdf
Feb 2019800
Mar 20193000
Apr 20191000
May 20192000
Jun 2019800
Jul 20192801
Aug 20191400
Sep 20191600
Oct 20191404
Nov 2019600
Dec 20191400
Jan 20201400
Feb 20201200
Mar 2020800
Apr 2020800
May 20201800
Jun 20201200
Jul 20202600
Aug 20201600
Sep 20202800
Oct 20202202
Nov 20202800
Dec 20201400
Jan 20211800
Feb 20213101
Mar 20211200
Apr 20212201
May 2021300
Aug 2021001
Oct 20211900
Nov 20211200
Dec 20211001
Jan 20222600
Feb 20226400
Mar 20224000
Apr 20223400
May 20227201
Jun 20224800
Jul 20223601
Aug 20227003
Sep 20225804
Oct 20225400
Nov 20224806
Dec 20223001
Jan 20232801
Feb 20236602
Mar 20231600
Total1191030